A newly launched $5 million clinical trial program allows clinical trial sponsors to start trials in as little as 45…

Clinical trials are facing an enrollment crisis. Around 80% of trials don’t meet their enrollment timelines, and fewer than 5%…

AI drug discovery company Owkin has signed a pact with French drugmaker Servier to license Owkin’s AI scientist K Pro…

Clinical research company nPhase has launched an end-to-end clinical data management platform designed to help trial sponsors leverage trial results…

Fortrea has agreed to acquire the early-phase services division of fellow CRO Worldwide Clinical Trials for $45 million.

Charles River Laboratories and Taiwan-based Medigen Vaccine Biologics are teaming up to advance Medigen’s multivalent enterovirus vaccine.

Oncology R&D organization Sarah Cannon Research Institute (SCRI) announced a collaboration with Merck & Co. to increase patient access to…

A new analysis from the Tufts Center for the Study of Drug Development (CSDD) found that an AI clinical monitoring…

Contract research organization Icon announced a multi-year collaboration with Anthropic this week to bring Claude’s AI capabilities to clinical trials.

The founders of contract research organization Quartesian have reunited to form Acrosian, a CRO designed to be purpose-built for the…